Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The glutamate receptor ionotropic AMPA type (AMPA receptor, AMPAR) is a ligand-gated ion channel that mediates fast excitatory synaptic transmission in the central nervous system[3][2]. It is a tetrameric protein complex composed of four subunits (GluA1–GluA4, encoded by GRIA1–4), forming a central ion-conducting pore permeable primarily to sodium (Na⁺) and, depending on subunit composition and RNA editing, sometimes calcium (Ca²⁺)[1][2][3]. AMPA receptors are activated by glutamate, the main excitatory neurotransmitter in the brain, and play a vital role in synaptic plasticity, learning, and memory. The structural complexity includes an extracellular amino-terminal domain (NTD), ligand-binding domain (LBD), transmembrane domain (forming the channel), and cytoplasmic C-terminal domain (CTD). Auxiliary proteins such as TARPs and CNIHs modulate AMPAR function, trafficking, and gating[6][4]. AMPAR dysfunction or dysregulation is implicated in neurodegenerative diseases, epilepsy, ischemia, and some psychiatric disorders[3]. Pharmacologically, it is an established target for antiepileptic and neuroprotective drugs, but modulating AMPAR activity is challenging due to its fundamental physiological role and the risk of adverse cognitive and neuropsychiatric effects[2].
Antagonists: block glutamate-mediated current through the AMPA receptor ion channel, reducing excitatory neurotransmission (e.g., perampanel is a non-competitive antagonist)[2][5] Positive allosteric modulators: enhance synaptic response by stabilizing the active (open) state
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutamate receptor ionotropic AMPA type (AMPA receptor (or AMPAR)).